Aster Capital Management (Difc) LTD 89bio, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $540 Billion
- Q1 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in 89bio, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 1,582 shares of ETNB stock, worth $15,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,582
Previous 602
162.79%
Holding current value
$15,566
Previous $4.71 Million
210.15%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ETNB
# of Institutions
208Shares Held
158MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$201 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$196 Million3.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.3MShares$141 Million4.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.32MShares$91.7 Million2.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$70.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $457M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...